Can you do better than the experts in treating immunoglobulin A nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS)? Using case-based vignettes, chairperson Siân Griffin, MD, PhD, and faculty members Jürgen Floege, MD, and Loreto Gesualdo, MD, will provide expert analysis regarding the value of lowering proteinuria and offer insights on applying clinical trial data to the unique challenges of managing advanced nephropathy. Learn how novel mechanisms, innovative treatments, and emerging data are achieving successful outcomes in patients with IgAN and FSGS.
Achieving Success in IgAN & FSGS: Expert Insights on Current and Future Therapies
Achieving Success in IgAN & FSGS: Expert Insights on Current and Future Therapies
0
- Host: Siân Griffin, MD, PhD
- Guest: Jürgen Floege, MD
- Guest: Loreto Gesualdo, MD, FERA
Review underlying mechanisms of glomerulonephritis and sclerosis in patients with IgAN and FSGS and find out how emerging data may improve outcomes.
Provider(s)/Educational Partner(s)
Our ultimate goal is to improve the care being delivered to patients, and our high-quality, evidence-based CME initiatives reflect our dedication to the creation and execution of excellence and are the product of shared research, knowledge, and clinical practice skills across the healthcare continuum.
Commercial Support
This activity is supported by an independent educational grant from CSL Vifor.
Related
Recommended
- Crohn’s & Colitis Foundation Perspectives
A Message from the President & CEO of Crohn’s & Colitis Foundation
- Crohn’s & Colitis Foundation Perspectives
The Crohn’s & Colitis Foundation's Camp Oasis: A Patient's Perspective
- Crohn’s & Colitis Foundation Perspectives
Surgical Management of Crohn's Disease & Ulcerative Colitis
- Crohn’s & Colitis Foundation Perspectives
Growing Up With IBD: When to Transition to an Adult GI Specialist
Facebook Comments